Mupirocin Calcium
Click to View Image
C52H86CaO18·2H2O 1075.34

Nonanoic acid, 9-[[3-Methyl-1-oxo-4-[tetrahydro-3,4-dihydroxy-5-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-2H-pyran-2-yl]-2-butenyl]oxy-, calcium salt (2:1), dihydrate, [2S-[2(E),3,4,5[2R*,3R*(1R*,2R*)]]]-.
(E,2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-Epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy--methyl-2H-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid, calcium salt (2:1), dihydrate [115074-43-6].
» Mupirocin Calcium contains the equivalent of not less than 865 µg and not more than 936 µg of mupirocin (C26H44O9) per mg.
Packaging and storage Preserve in tight containers. Store at 25, excursions permitted between 15 and 30.
USP Reference standards 11
USP Mupirocin Calcium RS.

USP Mupirocin Lithium RS Click to View Structure .
Change to read:
Identification—
A: Infrared Absorption 197M[note—Do not dry or grind extensively.]
B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.USP32
C: When moistened with hydrochloric acid, it meets the requirements of the flame test for Calcium 191.
Specific rotation 781S: between –16 and –20.
Test solution: 50 mg per mL, in methanol.
Water, Method I 921: not less than 3.0% and not more than 4.5%.
Chloride 221 Dissolve 50 mg in a mixture of 1 mL of 2 N nitric acid and 15 mL of methanol. Add 1 mL of silver nitrate TS: the turbidity does not exceed that produced by 0.70 mL of 0.020 N hydrochloric acid (0.5%).
Change to read:
Related compounds—
0.1 M Ammonium acetate— Prepare as directed in the Assay.
Mobile phase— Prepare a filtered and degassed mixture of 0.1 M Ammonium acetate and tetrahydrofuran (70:30). Make adjustments if necessary (see System Suitability under Chromatography 621).
pH 4 Acetate buffer— Transfer about 13.6 g of sodium acetate to a 1000-mL volumetric flask, and dissolve in about 900 mL of water. Adjust with glacial acetic acid to a pH of 4.0, and dilute with water to volume.
Diluent— Prepare a mixture of pH 4 Acetate buffer and methanol (1:1).
Standard solution— Transfer about 25 mg of USP Mupirocin Lithium RS, accurately weighed, to a 200-mL volumetric flask, dissolve in and dilute with Diluent to volume, and mix.
Test solution— Transfer about 50 mg of Mupirocin Calcium, accurately weighed, to a 10-mL volumetric flask, dissolve in and dilute with Diluent to volume, and mix.
Resolution solution— Adjust 10 mL of the Standard solution with 6 N hydrochloric acid to a pH of 2.0, allow to stand for 20 hours, and adjust with 5 N sodium hydroxide to a pH of 4.0.
Chromatographic system (see Chromatography 621) The liquid chromatograph is equipped with a 240-nm detector and a 4.6-mm × 25-cm column that contains 5-µm packing L7. The flow rate is about 1 mL per minute. Chromatograph the Resolution solution, and record the peak responses as directed for Procedure: two peaks are observed at retention times of about 0.63 and 0.67 relative to mupirocin. These peaks correspond to mupirocin rearrangement products. The resolution, R, between the second of these two peaks and the peak corresponding to mupirocin is not less than 7.0.USP32 Chromatograph the Standard solution, and record the peak responses as directed for Procedure: USP32 the column efficiency for the mupirocin peak is not less than 3000 theoretical plates; the tailing factor for the mupirocin peak is not more than 2; and the relative standard deviation of the mupirocin peak for replicate injections is not more than 5%.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard solution and the Test solution into the chromatograph, and measure the peak area responses for all of the peaks. Calculate the percentage of each related compound in the portion of Mupirocin Calcium taken by the formula:
(CS / CU)(ri / rS)(P/1000)(100)USP32
in which CS is the concentration, in mg per mL, of USP Mupirocin Lithium RS in the Standard solution; CU is the concentration, in mg per mL, of Mupirocin Calcium in the Test solution;USP32 ri is the peak area for any impurity obtained from the Test solution; rS is the peak area for mupirocin obtained from the Standard solution; and P/1000 is the potency of mupirocin, converted to mg per mg, of USP Mupirocin Lithium RS.USP32 Disregard any peak with an area less than 0.05 times the area of the mupirocin peak in the chromatogram obtained from the Standard solution.
Peak
Identification
Relative
Retention Time
Limit
(%, w/w)
Pseudomonic acid D1 0.75 NMT 2.5
Mupirocin 1.0
Any other unspecified impurity NMT 1
Total impurities NMT 4.5
1  (E)-9-{(E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyloxy}non-4-enoic acid.
USP32
Change to read:
Assay—
0.1 M Ammonium acetate— Transfer about 7.7 g of ammonium acetate to a 1000-mL volumetric flask, dissolve in about 900 mL of water, adjust with glacial acetic acid to a pH of 5.7, and dilute with water to volume.
Mobile phase— Prepare a filtered and degassed mixture of 0.1 M Ammonium acetate and tetrahydrofuran (68:32). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Transfer about 25 mg of USP Mupirocin Lithium RS, accurately weighed, to a 200-mL volumetric flask, dissolve in 5 mL of methanol, dilute with 0.1 M Ammonium acetate to volume, and mix.
Assay preparation— Transfer about 25 mg of Mupirocin Calcium, accurately weighed, to a 200-mL volumetric flask, dissolve in 5 mL of methanol, dilute with 0.1 M Ammonium acetate to volume, and mix.
Resolution solution— Adjust 10 mL of the Standard preparation with 6 N hydrochloric acid to a pH of 2.0, and allow to stand for 20 hours.
Chromatographic system (see Chromatography 621) The liquid chromatograph is equipped with a 230-nm detector and a 4.6-mm × 25-cm column that contains 5-µm packing L7. The flow rate is about 1 mL per minute. Chromatograph the Resolution solution, and record the peak responses as directed for Procedure: the resolution, R, of the second of the two peaks corresponding to mupirocin rearrangement products and the peak corresponding to mupirocin is not less than 7.0. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the relative standard deviation for replicate injections is not more than 1.0%.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, and measure the peak area responses for the major peaks. Calculate the quantity, in µg, of mupirocin (C26H44O9) in each mg of Mupirocin Calcium taken by the formula:
P(CS / CU)(rU / rS)
in which P is the potency, in µg, of mupirocin in each mg of USP Mupirocin Lithium RS; CS is the concentration, in mg per mL, of USP Mupirocin Lithium RS in the Standard preparation; CU is the concentration, in mg per mL, of Mupirocin Calcium in the Assay preparation;USP32 and rU and rS are the mupirocin peak area responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ahalya Wise, M.S.
Scientist
1-301-816-8161
(MDANT05) Monograph Development-Antibiotics
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
USP32–NF27 Page 3012
Pharmacopeial Forum: Volume No. 34(1) Page 101
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.